124 related articles for article (PubMed ID: 22772062)
1. Cyclin I correlates with VEGFR-2 and cell proliferation in human epithelial ovarian cancer.
Cybulski M; Jarosz B; Nowakowski A; Jeleniewicz W; Seroczyński P; Mazurek-Kociubowska M
Gynecol Oncol; 2012 Oct; 127(1):217-22. PubMed ID: 22772062
[TBL] [Abstract][Full Text] [Related]
2. Expression of GLUT-1 in epithelial ovarian carcinoma: correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction.
Semaan A; Munkarah AR; Arabi H; Bandyopadhyay S; Seward S; Kumar S; Qazi A; Hussein Y; Morris RT; Ali-Fehmi R
Gynecol Oncol; 2011 Apr; 121(1):181-6. PubMed ID: 21167567
[TBL] [Abstract][Full Text] [Related]
3. Cyclin A correlates with YB1, progression and resistance to chemotherapy in human epithelial ovarian cancer.
Cybulski M; Jarosz B; Nowakowski A; Jeleniewicz W; Kutarska E; Bednarek W; Stepulak A
Anticancer Res; 2015 Mar; 35(3):1715-21. PubMed ID: 25750333
[TBL] [Abstract][Full Text] [Related]
4. The role of Cyclin G1 in cellular proliferation and apoptosis of human epithelial ovarian cancer.
Jiang L; Liu R; Wang Y; Li C; Xi Q; Zhong J; Liu J; Yang S; Wang J; Huang M; Tang C; Fang Z
J Mol Histol; 2015 Jun; 46(3):291-302. PubMed ID: 25981880
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
Nishida N; Yano H; Komai K; Nishida T; Kamura T; Kojiro M
Cancer; 2004 Sep; 101(6):1364-74. PubMed ID: 15368324
[TBL] [Abstract][Full Text] [Related]
6. Cyclin I mRNA expression correlates with kinase insert domain receptor expression in human epithelial ovarian cancer.
Cybulski M; Jeleniewicz W; Nowakowski A; Stenzel-Bembenek A; Tarkowski R; Kotarski J; Stepulak A
Anticancer Res; 2015 Feb; 35(2):1115-9. PubMed ID: 25667501
[TBL] [Abstract][Full Text] [Related]
7. The Role of Angiogenesis in the Persistence of Chemoresistance in Epithelial Ovarian Cancer.
Nusrat O; Belotte J; Fletcher NM; Memaj I; Saed MG; Diamond MP; Saed GM
Reprod Sci; 2016 Nov; 23(11):1484-1492. PubMed ID: 27122375
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between TEMs and endothelial cells modulates angiogenesis and metastasis via IGF1-IGF1R signalling in epithelial ovarian cancer.
Wang X; Zhu Q; Lin Y; Wu L; Wu X; Wang K; He Q; Xu C; Wan X; Wang X
Br J Cancer; 2017 Oct; 117(9):1371-1382. PubMed ID: 28898232
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of VEGF, miR-205 and target protein Ezrin and Lamin A/C in ovarian cancer].
Zhou J; Liu H; Chen Y; Wen J; Li L; Wu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Feb; 39(2):142-50. PubMed ID: 24608381
[TBL] [Abstract][Full Text] [Related]
10. The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC).
Dutta S; Wang FQ; Wu HS; Mukherjee TJ; Fishman DA
Gynecol Oncol; 2011 Oct; 123(1):129-37. PubMed ID: 21782227
[TBL] [Abstract][Full Text] [Related]
11. Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer.
Huang B; Yin M; Li X; Cao G; Qi J; Lou G; Sheng S; Kou J; Chen K; Yu B
Oncotarget; 2016 May; 7(19):27552-66. PubMed ID: 27050277
[TBL] [Abstract][Full Text] [Related]
12. VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion.
Wang FQ; Barfield E; Dutta S; Pua T; Fishman DA
Gynecol Oncol; 2009 Dec; 115(3):414-23. PubMed ID: 19765808
[TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1α and vascular endothelial growth factor.
Zhang Y; Xu Y; Ma J; Pang X; Dong M
Sci Rep; 2017 Jan; 7():40524. PubMed ID: 28091613
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine kinase A receptor (trkA): a potential marker in epithelial ovarian cancer.
Tapia V; Gabler F; Muñoz M; Yazigi R; Paredes A; Selman A; Vega M; Romero C
Gynecol Oncol; 2011 Apr; 121(1):13-23. PubMed ID: 21236475
[TBL] [Abstract][Full Text] [Related]
15. Emerging Role of Nestin as an Angiogenesis and Cancer Stem Cell Marker in Epithelial Ovarian Cancer: Immunohistochemical Study.
Osman WM; Shash LS; Ahmed NS
Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):571-580. PubMed ID: 26945442
[TBL] [Abstract][Full Text] [Related]
16. Proliferation and maturation of intratumoral blood vessels in women with malignant ovarian tumors assessed with cancer stem cells marker nestin and platelet derived growth factor PDGF-B.
Czekierdowska S; Stachowicz N; Chróściel M; Czekierdowski A
Ginekol Pol; 2017; 88(3):120-128. PubMed ID: 28397199
[TBL] [Abstract][Full Text] [Related]
17. The associations between serum VEGF, bFGF and endoglin levels with microvessel density and expression of proangiogenic factors in malignant and benign ovarian tumors.
Szubert S; Moszynski R; Michalak S; Nowicki M; Sajdak S; Szpurek D
Microvasc Res; 2016 Sep; 107():91-6. PubMed ID: 27312585
[TBL] [Abstract][Full Text] [Related]
18. Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer.
Xi C; Ren C; Hu A; Lin J; Yao Q; Wang Y; Gao Z; An X; Liu C
Gynecol Oncol; 2013 Dec; 131(3):764-71. PubMed ID: 23994105
[TBL] [Abstract][Full Text] [Related]
19. Extracellular matrix metalloproteinase inducer (EMMPRIN) expression correlates positively with active angiogenesis and negatively with basic fibroblast growth factor expression in epithelial ovarian cancer.
Szubert S; Szpurek D; Moszynski R; Nowicki M; Frankowski A; Sajdak S; Michalak S
J Cancer Res Clin Oncol; 2014 Mar; 140(3):361-9. PubMed ID: 24374756
[TBL] [Abstract][Full Text] [Related]
20. A novel mechanism of neovascularization in peritoneal dissemination via cancer-associated mesothelial cells affected by TGF-β derived from ovarian cancer.
Fujikake K; Kajiyama H; Yoshihara M; Nishino K; Yoshikawa N; Utsumi F; Suzuki S; Niimi K; Sakata J; Mitsui H; Shibata K; Senga T; Kikkawa F
Oncol Rep; 2018 Jan; 39(1):193-200. PubMed ID: 29192324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
